Discounted Cash Flow
Sanara Medtech Inc.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | $5.5m | $-415.7k | $406.2k | -7.5% | $-0.01 |
| 2017 | $6.3m (14.5%) | $331.3k (179.7%) | $-183.8k (-145.2%) | 5.3% (169.6%) | $0.00 (100.0%) |
| 2018 | $5.8m (-7.4%) | $-600.6k (-281.3%) | $268.7k (246.2%) | -10.3% (-295.8%) | $0.00 |
| 2019 | $11.8m (101.6%) | $-2.8m (-368.6%) | $-2.4m (-974.8%) | -23.9% (-132.5%) | $-1.32 |
| 2020 | $15.6m (32.5%) | $-4.4m (-54.8%) | $-4.6m (-94.8%) | -27.9% (-16.9%) | $-0.76 (42.4%) |
| 2021 | $24.1m (54.9%) | $-8.0m (-83.5%) | $-5.0m (-8.9%) | -33.1% (-18.5%) | $-1.08 (-42.1%) |
| 2022 | $45.8m (89.9%) | $-7.9m (0.7%) | $-5.7m (-14.3%) | -17.3% (47.7%) | $-1.00 (7.4%) |
| 2023 | $65.0m (41.8%) | $-4.3m (45.8%) | $-3.5m (38.4%) | -6.6% (61.8%) | $-0.52 (48.0%) |
| 2024 | $86.7m (33.4%) | $-9.7m (-124.6%) | $-229.6k (93.5%) | -11.2% (-68.4%) | $-1.14 (-119.2%) |
| 2025 | $103.1m (19.0%) | $-37.6m (-288.7%) | $2.2m (1041.1%) | -36.4% (-226.7%) | $-4.36 (-282.5%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.